»» Searching for " Pfizer "
 Related Search Tags:  Nyse:pfe PFE Pfizer XALKORI LRAD MLNK NYSE:PFE Nasdaq:MLNK Nasdaq:LRAD
Showing Results 1-3 of 3 |  Sort by:     
Page 1 of 1  |  Go to page   
Thank you for joining us. I am your host Yohemy Auerbach at CRWE Newswire Stocks to watch. Pfizer Incorporated - symbol PFE - reported that the U.S. Food and Drug Administration has approved its XALKORI. the first-ever therapy targeting anaplastic lymphoma kinase, for the treatment of patients with locally advanced or metastatic non-small cell lung cancer that is anaplastic lymphoma kinase-positive as detected by an FDA-approved test. lung cancer is responsible for more deaths in both men and women each year worldwide than any other type of cancer. Pfizer’s XALKORI is an advance in the treatment of this devastating illness, providing a new therapeutic option for a subset of patients with the disease. Pfizer Oncology is committed to the discovery, investigation and development of innovative treatment options to improve the outlook for cancer patients worldwide. Thank you for tuning in, have a great day. For CRWE Newswire, Stocks to watch, I’m Yohemy Auerbach.
Pfizer (PFE) FDA Approves...
Categories: Videos 
Added: 268 days ago
By: karmastock
Runtime: 1m32s
Views: 92
 | Comments: 0
Not yet rated
Welcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera. Pfizer Inc - PFE - reported that the FDA has granted approval of the Company’s pneumococcal conjugate vaccine Prevnar 13 for the Prevention of Pneumococcal Pneumonia and Invasive Disease in Adults 50 Years and Older. Pneumococcal disease, including pneumonia, in adults 50 years and older represents a significant personal and societal health burden in the United States. Pfizer is committed to applying science and its global resources to improve health and well-being at every stage of life. hanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I’m Shalika Jayasekera
FDA Approves Pfizer\\\'s...
Categories: Videos 
Added: 142 days ago
By: karmastock
Runtime: 1m0s
Views: 78
 | Comments: 0
Not yet rated
Welcome to CRWENewswire, Stocks to Watch for Tuesday December 6th, 2011. I am Shalika Jayasekera. On its fiscal year 2011, LRAD Corp - LRAD - posted record revenues of $26.5 million and record net income of $0.15 per diluted share, representing record Company revenues for the fourth straight fiscal year and second consecutive year of profitability. ModusLink Global Solutions Inc - MLNK - reported financial results for its first quarter fiscal 2012, posting Net income of $1.6 million, compared to net loss of $6.7 million in the same period a year ago. and finally; Pfizer Inc - PFE - reported that its Toviaz Shows Positive Top-Line Primary Endpoint Result In Study Of Overactive Bladder In Vulnerable Elderly Patients. Thanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I’m Shalika Jayasekera
(PFE, LRAD, MLNK)...
Categories: Videos 
Added: 168 days ago
By: karmastock
Runtime: 1m17s
Views: 44
 | Comments: 0
Not yet rated
Page 1 of 1  |  Go to page   
About Us   |   Terms of Use   |   Privacy Policy   |   Copyright Notes   |   Contact Us   |   Help   |      |   Back to the top of this page
Copyright © 2006-2007 bongoTYube. All rights reserved.    | Page created in 0.1421 seconds.